hengdu,China, April 17th, 2017, HitGen Ltd. is pleased to announce that the companyhas entered into a multi-year research collaboration and license agreement with Pfizer Inc. (NYSE: PFE) to build and screen novelDNA-encoded libraries (DELs) .
hengdu,China, April 17th, 2017, HitGen Ltd. is pleased to announce that the companyhas entered into a multi-year research collaboration and license agreement with Pfizer Inc. (NYSE: PFE) to build and screen novelDNA-encoded libraries (DELs) .